American Society of Addiction Medicine
American Society of Addiction Medicine
Lead Story: Trends and Characteristics of Buprenorphine-Involved Overdose Deaths Prior to and During the COVID-19 Pandemic
Lead Story: Trends and Characteristics of Buprenorphine-Involved Overdose Deaths Prior to and During the COVID-19 Pandemic
Lead Story: Trends and Characteristics of Buprenorphine-Involved Overdose Deaths Prior to and During the COVID-19 Pandemic
Tuesday 31st January 2023
Uncover trends in buprenorphine overdose deaths during COVID-19 and other key addiction insights in this episode of Addiction Medicine Unpacked.
7 minutes
Informative
Thought-provoking
Empowering
Educational
Engaging
About this podcast
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Episodes:
144 (View all)
Do you want to link to this podcast?
Get the buttons here!Buprenorphine Overdose Deaths During COVID-19: Surprising Findings
Buprenorphine was involved in nearly 2.2% of all drug overdose deaths and 2.6% of opioid-involved overdose deaths.
Have you ever wondered how the pandemic has influenced opioid overdose deaths, especially those involving buprenorphine? In this episode of 'Addiction Medicine Unpacked', host Claire Rasmussen dives into a revealing study from JAMA Network Open. The research examines 74,474 opioid-involved overdose deaths across 46 states and the District of Columbia, comparing data from before and during the COVID-19 pandemic.
While opioid-involved overdose deaths surged during this period, the rate of buprenorphine-involved deaths remained stable, accounting for 2.2% of all drug overdose deaths and 2.6% of opioid-related deaths. Intriguingly, a higher proportion of these deaths involved females, non-Hispanic Whites, and individuals living in rural areas. The episode also explores other significant studies in addiction medicine, such as the effects of alcohol on depression, the impact of racial discrimination on tobacco and cannabis use, and disparities in emergency department-initiated buprenorphine treatments.
Additional discussions include race differences in binge drinking treatment, the link between adverse childhood experiences and overdose risks, and how amphetamines affect fentanyl-induced respiratory depression. This episode offers a wealth of information for anyone interested in the opioid crisis and addiction treatment advancements. It emphasizes the critical need for ongoing research to develop effective strategies for combating addiction and improving lives.